NCT06411223 - Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Hiv

Interventions

BEHAVIORAL

Collaborative drug therapy management model

CDTM+ is an interdisciplinary approach to patient care in which clinicians collaborate with pharmacists to provide and manage patient drug therapy.

DRUG

Cabotegravir/Rilpivirine

Long-acting injectable treatment prescribed to treat HIV-1 infection in people 12 years and older and who weigh at least 77 lbs (35kg), to replace their current HIV-1 medicines when their healthcare provider determines they meet certain requirements.

Trial Locations (1)

06519

RECRUITING

Yale Clinical and Community Research, New Haven